SAN FRANCISCO , April 15, 2024 /PRNewswire/ -- LEGAL NOTICE Third-Party Payors: If you paid or reimbursed costs for prescription opioids, or paid or incurred costs for treatment related to opioid misuse, addiction, and/or overdose, ...
Read MoreProvides MarVax™ Heat Stable Vaccine Seven Years of U.S. Market Exclusivity Upon FDA Approval PRINCETON, N.J. , April 15, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage ...
Read MoreThe partnership emphasizes the healing benefits of compassion and its ability to connect us all TORONTO , April 15, 2024 /CNW/ - Popular children's show Nanalan' , is teaming up with the Canadian Mental Health Association (CMHA) to ...
Read MoreMONTREAL , April 12, 2024 /CNW/ - The Montreal -based law firms Fishman Flanz Meland Paquin LLP (" FFMP ") and Trudel Johnston & Lespérance (" TJL ") are pleased to announce that, by judgment released on April 10, 2024 , the ...
Read MoreMiniature, wireless and battery-free bioelectronic stimulator with potential application in psychiatric disorders HOUSTON , April 12, 2024 /PRNewswire/ -- Rice University today announced that Jacob Robinson , a professor of electrical ...
Read MoreMONTREAL , April 12, 2024 /CNW/ - Canada is deviating from meeting the 2030 objectives established by the World Health Organization (WHO) to be on the path to eliminating cervical cancer. Our Expert Panel's mandate is to analyse and make ...
Read MoreCHICAGO , April 11, 2024 /PRNewswire/ -- Signifying a monumental step forward in the domain of powered antibody therapies, SparX is thrilled to announce that the first patient has been successfully dosed with SPX-303, a First-in-Class ...
Read MoreFN Media Group Presents USA News Group News Commentary VANCOUVER, BC , April 11, 2024 /PRNewswire/ -- USA News Group – The American Cancer Society is projecting 2024 to be the first year ever for the US to have more than 2 ...
Read MoreTo promote public awareness of head and neck cancer, board-certified oral and maxillofacial surgeons share facts and tips CHICAGO , April 11, 2024 /PRNewswire/ -- The Executive Board and Diplomates of the American Board of Oral and ...
Read MoreNew Technology Development and Extended Partnership Leads to Extended Relationship LEAWOOD, Kan. , April 11, 2024 /PRNewswire/ -- CViConnect ( cviconnect.co and pro.cviconnect.co ), based in Leawood, Kansas , and provider of the ...
Read MoreAUSTIN, Texas , April 11, 2024 /PRNewswire/ -- Stamford Pharmaceuticals Inc, a clinical-stage biotechnology company developing science-driven immune therapies, today announced initiation of its locally advanced basal cell carcinoma (laBCC) ...
Read MoreCLEVELAND , April 11, 2024 /PRNewswire/ -- More hope for successfully combating some of the deadliest cancers. Lamassu Biotech is proud to announce its pioneering effort to combat locally advanced metastatic p53 wild-type tumors has earned ...
Read MoreProvides SuVax™ Heat Stable Vaccine Seven Years of U.S. Market Exclusivity Upon FDA Approval PRINCETON, N.J. , April 11, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical ...
Read MoreMIAMI , April 11, 2024 /PRNewswire/ -- Researchers have developed a functional precision medicine approach that targets cancer by combining genetic testing with a new way to test individual drugs on tumor samples. The results of the ...
Read MoreMr. Tim German's 2017 Hyundai Elantra a.k.a. "Dark Angel," was bought new from Steele Hyundai Halifax and now has more than 760,000 kilometres on the odometer. With his Elantra, Mr. German delivers STAT blood products throughout New Brunswick ...
Read MoreSen-Jam Pharmaceutical has entered their third development, manufacturing, distribution and license agreement with KVK-Tech. This is a monumental milestone for the company and great news for their promising multi-use anti-inflammatory ...
Read MoreFollowing success in BC, Cognito brings its all-in-one mental health treatment to Ontario offering virtual therapy, medication and an integrated care team in one easy subscription. VICTORIA, British Columbia , April 10, 2024 ...
Read MoreThe collaboration will focus on perfecting daily usage models, mitigations and interventions that maximize cognitive performance and create a process to achieve desired outcomes BOSTON , April 10, 2024 /PRNewswire/ -- Pison , the ...
Read MorePOCATELLO, Idaho , April 10, 2024 /PRNewswire/ -- Startling statistic: Nearly half of the Earth's adult population struggles with oral infection, and for many it will be fatal. For seniors, the number jumps to seven out of ten. "For the ...
Read MoreSHENZHEN, China , April 9, 2024 /PRNewswire/ -- Recently, Kexing Biopharm (688136.SH) announced that the Phase III clinical trial of Human Interferon a1b Inhalation Solution developed by its wholly-owned subsidiary, Shenzhen Kexing ...
Read MoreSHANGHAI , April 9, 2024 /PRNewswire/ -- BioCity Biopharma today announced that the U.S. Food and Drug Administration (FDA) has cleared the company's Investigational New Drug (IND) application for a Phase 1 study of BC2027. BC2027, which is ...
Read MoreMommy's Bliss Aims to Support Breastfeeding Mothers With a Delicious and Convenient New Hydration Product RICHMOND, Calif. , April 9, 2024 /PRNewswire-PRWeb/ -- Mommy's Bliss , a premier wellness company that has been a leader in bringing ...
Read MoreBATON ROUGE, La. , April 9, 2024 /PRNewswire/ -- As Anaplasmosis continues to extend its infectious reach beyond the southeastern United States , University Products remains at the forefront of defense. Traditionally confined to certain ...
Read MoreSHANGHAI and SAN DIEGO , April 9, 2024 /PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, today unveiled the latest research findings of GFH375, an ...
Read MoreNT-I7 maintains cancer-specific T-cell amplifying efficacy when combined with standard of care colorectal cancer therapy FOLFOX ® Study indicates interest for potential combination therapy with chemotherapeutic agents. ROCKVILLE, Md. ...
Read MoreAUSTIN, Texas , April 9, 2024 /PRNewswire/ -- Electrophysiologists at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center became the first in the nation to use a novel pulsed field ablation (PFA) system to treat patients ...
Read MorePRINCETON, N.J. and SUZHOU, China , April 8, 2024 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development ...
Read MoreSHANGHAI , April 8, 2024 /PRNewswire/ -- 9 April 2024 (Beijing Time) , Abbisko Therapeutics Co., Ltd. (Abbisko Therapeutics) announced the completion of patient enrollment for its pivotal Phase III trial, MANEUVER (ABSK021-301) STUDY, for ...
Read MoreSAN DIEGO , April 8, 2024 /PRNewswire/ -- Akeso, Inc. (9926.HK) today announced that the positive interim analysis results from Phase III clinical study of Cadonilimab (PD-1/CTLA-4 BsAb) combined with XELOX (capecitabine plus ...
Read MoreTORONTO , April 8, 2024 /PRNewswire/ -- Nearly one million people in the U.S. are currently living with Parkinson's disease (PD), a figure expected to surge to 1.2 million by 2030. As the second-most common neurodegenerative disease after ...
Read MoreSubscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers